Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Chemicals from the plant Dicerocaryum senecioides were found to safely speed up and increase hair growth in mice.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Antioxidants might help prevent pressure ulcers, but more research is needed to find effective ones.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Innovative methods are reducing animal testing and improving biomedical research.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Tofacitinib may help treat severe hair loss, but more research is needed.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

New acne treatments show promise as alternatives to traditional therapies.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.